找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Genitourinary Cancer 1; David F. Paulson (Associate Professor of Urology) Book 1982 Martinus Nijhoff Publishers bv, The Hague 1982 carcino

[復制鏈接]
樓主: 母牛膽小鬼
21#
發(fā)表于 2025-3-25 06:15:58 | 只看該作者
22#
發(fā)表于 2025-3-25 08:44:11 | 只看該作者
23#
發(fā)表于 2025-3-25 14:46:14 | 只看該作者
Assessment of Biologic Hazard of Urologic Tumors,the treatment groups are equal with respect to disease risk. Five broad categories: (1) the tumor pathology, (2) the stage of the disease, (3) biologic markers, (4) the type of treatment, and (5) the pattern of metastatic disease have been shown to have prognostic significance.
24#
發(fā)表于 2025-3-25 17:09:41 | 只看該作者
25#
發(fā)表于 2025-3-25 22:20:11 | 只看該作者
26#
發(fā)表于 2025-3-26 03:27:02 | 只看該作者
27#
發(fā)表于 2025-3-26 04:32:02 | 只看該作者
Current Status of Androgen Receptor Measurements in Prostatic Cancer,at the time of its discovery [1, 2]. Since the discovery by Huggins and Hodges that prostatic cancer is an androgen-dependent tumor the treatment of advanced prostatic cancer has centered on methods designed to decrease circulating levels of androgen [3]. The majority of patients so treated, either
28#
發(fā)表于 2025-3-26 11:48:39 | 只看該作者
29#
發(fā)表于 2025-3-26 12:46:01 | 只看該作者
Physical basis of dermatologic radiotherapy,s chemotherapy are usually reserved for patients who fail to respond to a trial of hormonal therapy [6]. Thus, if one could identify those patients unlikely to obtain a prolonged response to hormonal manipulation they could be spared the side-effects of an unsuccessful course of hormonal therapy and
30#
發(fā)表于 2025-3-26 19:23:49 | 只看該作者
Current Status of Androgen Receptor Measurements in Prostatic Cancer,s chemotherapy are usually reserved for patients who fail to respond to a trial of hormonal therapy [6]. Thus, if one could identify those patients unlikely to obtain a prolonged response to hormonal manipulation they could be spared the side-effects of an unsuccessful course of hormonal therapy and
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 04:50
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復 返回頂部 返回列表
景谷| 沾化县| 天津市| 平度市| 三门县| 岱山县| 揭东县| 辰溪县| 怀来县| 云南省| 盐津县| 绥化市| 车险| 大方县| 拜泉县| 鄂州市| 平和县| 兰州市| 长汀县| 崇阳县| 扎鲁特旗| 塔城市| 潮安县| 水城县| 慈溪市| 菏泽市| 巨野县| 漠河县| 南平市| 浮梁县| 柘城县| 万山特区| 马龙县| 堆龙德庆县| 芜湖市| 顺昌县| 乌兰察布市| 弥勒县| 昌宁县| 岐山县| 清水河县|